Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avantor, Inc.AVTR · Entity 3546 | Director | May 07, 2026 | May 11, 2026 |
| Bruker Cellular Analysis, Inc.CELL · Entity 109250 | Director | October 02, 2023 | October 03, 2023 |
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | June 03, 2026 | June 05, 2026 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avantor, Inc.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,006 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 25,270 · Balance 34,006 F1: Reflects a grant of restricted stock units that vests on May 7, 2027. |
| Common StockSEC Table I · non-derivative | IndirectBy a Trust | 60,000 |
Reported balance
After 2026-05-08 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-05-08 · Purchase · Acquired 10,000 · Balance 60,000 F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F3: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vests on May 7, 2027.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
F3: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Bruker Cellular Analysis, Inc.
Report date October 02, 2023 · Filed October 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 136,062 |
Reported balance
After 2023-10-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-10-02 · Exercise / conversion · Disposed 70,000 · Balance 136,062 F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration"). F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration. |
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 0 |
Reported balance
After 2023-10-02 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-10-02 · Disposition to issuer · Disposed 136,062 · Balance 0 F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the "Merger Consideration. F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration").
F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration.
F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the "Merger Consideration.
F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration.
DENTSPLY SIRONA Inc.
Report date June 03, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-06-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-03 · Grant · Acquired 38,382 · Balance 38,382 F1: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Row 2 · 2026-06-03 · Gift · Disposed 38,382 · Balance 0 F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Partnership | 63,283.284 |
Reported balance
After 2026-06-03 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-06-03 · Gift · Acquired 38,382 · Balance 63,283.284 F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2036-06-03 | Direct | 10,900 |
Reported balance
After 2026-06-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-03 · Grant · Acquired 10,900 · Balance 10,900 F3: Stock Options vest in full one (1) year from date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2036-06-03 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-06-03 · Gift · Disposed 10,900 · Balance 0 F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. F3: Stock Options vest in full one (1) year from date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2026-06-05 | IndirectBy Family Partnership | 10,900 |
Reported balance
After 2026-06-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-06-03 · Gift · Acquired 10,900 · Balance 10,900 F3: Stock Options vest in full one (1) year from date of grant. F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. |
| Common StockSEC Table I · non-derivative | IndirectBy Gregory Lucier IRA | 21,000 |
Reported balance
Holding disclosure · report date 2026-06-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 21,000 |
| Common StockSEC Table I · non-derivative | IndirectBy a Trust | 65,000 |
Reported balance
Holding disclosure · report date 2026-06-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 65,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.
F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose.
F3: Stock Options vest in full one (1) year from date of grant.
F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 155,123 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Gift · Disposed 46,293 · Balance 155,123 F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Family Partnership | 156,077 |
Reported balance
After 2026-06-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-09 · Gift · Acquired 46,293 · Balance 156,077 F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Catalent, Inc.
Report date December 18, 2024 · Filed December 18, 2024
Section 16 reporting ended · disclosed 2024-12-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-12-18 transaction · row 1
1 source rowRow 1 · 2024-12-18 · Disposition to issuer · Disposed 36,914 · Balance 0 F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2: Includes restricted stock units ("RSUs"). F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration"). F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").
F2: Includes restricted stock units ("RSUs").
F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration").
F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms.
Invuity, Inc.
Report date October 23, 2018 · Filed October 23, 2018
Section 16 reporting ended · disclosed 2018-10-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-10-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-10-23 · Disposition to issuer · Disposed 99,219 · Balance 52,231 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Row 2 · 2018-10-23 · Disposition to issuer · Disposed 52,231 · Balance 0 F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2018-10-23 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-10-23 · Disposition to issuer · Disposed 18,245 · Balance 0 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4: The shares are held by RiverRoad Capital Partners, LLC, of which the Reporting Person is a managing member. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2024-01-21 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-23 · Disposition to issuer · Disposed 24,648 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.87 · Expires 2021-05-19 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-23 · Disposition to issuer · Disposed 28,900 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price").
F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock.
F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price.
F4: The shares are held by RiverRoad Capital Partners, LLC, of which the Reporting Person is a managing member.
F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.
NUVASIVE INC
Report date May 18, 2021 · Filed May 20, 2021
Section 16 reporting ended · disclosed 2021-05-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 257,939 |
Last balance in matching sequence
After 2021-05-18 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-05-18 · Exercise / conversion · Acquired 19,125 · Balance 266,344 F1: On May 18, 2021, the Reporting Person retired from his position as a member of the Issuer's Board of Directors. Pursuant to deferral elections made by the Reporting Person, all shares underlying Restricted Stock Units ("RSUs") subject to such deferrals will be delivered to the Reporting Person promptly following May 18, 2021, the date on which the Reporting Person retired. F2: Shares indirectly held by the Reporting Person. Row 2 · 2021-05-18 · Tax withholding · Disposed 8,405 · Balance 257,939 F3: Shares withheld by the Issuer to satisfy tax withholding obligations. F2: Shares indirectly held by the Reporting Person. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-05-18 · Exercise / conversion · Disposed 8,312 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-05-18 · Exercise / conversion · Disposed 1,416 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-05-18 · Exercise / conversion · Disposed 3,725 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F6: This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-05-18 · Exercise / conversion · Disposed 2,577 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F7: This RSU award was granted to the Reporting Person on May 9, 2019 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-05-18 · Exercise / conversion · Disposed 3,095 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F8: This RSU award was granted to the Reporting Person on May 28, 2020 and is fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 18, 2021, the Reporting Person retired from his position as a member of the Issuer's Board of Directors. Pursuant to deferral elections made by the Reporting Person, all shares underlying Restricted Stock Units ("RSUs") subject to such deferrals will be delivered to the Reporting Person promptly following May 18, 2021, the date on which the Reporting Person retired.
F2: Shares indirectly held by the Reporting Person.
F3: Shares withheld by the Issuer to satisfy tax withholding obligations.
F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested.
F6: This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested.
F7: This RSU award was granted to the Reporting Person on May 9, 2019 and is fully vested.
F8: This RSU award was granted to the Reporting Person on May 28, 2020 and is fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 12, 2024 Filed Apr 15, 2024 23:31 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 26.426 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-012905 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,169.08 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 12, 2024 Filed Jan 16, 2024 19:02 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 21.479 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-001315 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,142.654 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 21:34 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 10,000 | $31.44 | $314,400.00 |
DisclosureSEC source: 0001127602-23-028291 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,121.175 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $31.4200 to $31.4550, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 27, 2023 Filed Oct 31, 2023 20:30 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 6,993 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-23-000147 · wk-form4_1698784220.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,251 F1 · shares: The equity acquired by the reporting person is the annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award, subject to continued service. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 13, 2023 Filed Oct 16, 2023 21:03 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 48.731 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-025915 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,121.175 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 14:37 UTC | Bruker Cellular Analysis, Inc. CELL · Entity 109250 | Disposition to issuerCommon Stock | 136,062 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-019719 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Trust Disclosed balance after: 0 F3 · kind: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the "Merger Consideration. F3 · price: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the "Merger Consideration. F4 · price: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration. Read SEC document |
| October 02, 2023 Filed Oct 3, 2023 14:37 UTC | Bruker Cellular Analysis, Inc. CELL · Entity 109250 | Exercise / conversionCommon Stock | 70,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-019719 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Trust Disclosed balance after: 136,062 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration"). F1 · price: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration"). F2 · price: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 20:49 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 24,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001823239-23-000060 · wf-form4_168979975930213.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,123 F1 · shares: Represents restricted stock units granted on July 17, 2023, which vest in full upon the earlier of one year from the date of grant or the date of the 2024 Maravai LifeSciences Holdings, Inc. annual meeting of stockholders. Read SEC document |
| July 14, 2023 Filed Jul 17, 2023 21:17 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 41.45 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-020833 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,072.444 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 25, 2023 Filed May 26, 2023 20:52 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5,419 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-016975 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,030.994 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 25, 2023 Filed Jun 1, 2023 16:22 UTC | Bruker Cellular Analysis, Inc. CELL · Entity 109250 | GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-067052 · tm2317396d2_4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Family Trust Disclosed balance after: 206,062 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. F2 · balance_after: Includes 70,000 RSUs. Read SEC document |
| April 14, 2023 Filed Apr 18, 2023 21:06 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 22.836 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-013148 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,611.994 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| January 13, 2023 Filed Jan 13, 2023 21:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 25.055 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-001411 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,589.158 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 15, 2022 Filed Nov 15, 2022 21:15 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 6,000 | $31.45 | $188,700.00 |
DisclosureSEC source: 0001127602-22-025620 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Gregory Lucier IRA Disclosed balance after: 15,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $31.435 to $31.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 21:40 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 6,382 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-025780 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,564.103 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| October 27, 2022 Filed Oct 31, 2022 21:03 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 4,149 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-22-000175 · wf-form4_166725015812648.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,258 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-employee director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2023 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 26, 2022 Filed Aug 1, 2022 18:41 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | GrantStock Option (Right to Buy) · Derivative | 32,258 | $0.00 Strike: $4.60 | $0.00 |
DisclosureSEC source: 0001567619-22-014731 · doc1.xml · derivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,258 Underlying: Common Stock · 32,258 shares Expires 2032-05-25 F3 · derivative.exercise_date: The stock options will fully vest on May 26, 2023. Read SEC document |
| May 26, 2022 Filed Aug 1, 2022 18:41 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | GrantCommon Stock | 19,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-014731 · doc1.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 136,062 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest on May 26, 2023. F2 · balance_after: Includes 32,065 RSUs. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 21:59 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7.609 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-011852 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,182.103 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 20:12 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | PurchaseCommon Stock | 50,000 | $5.24 | $262,240.00 |
DisclosureSEC source: 0001567619-22-007008 · doc1.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,323 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $5.105 to $5.43. The reporting person undertakes to provide Berkeley Lights, Inc (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 10, 2022 Filed Mar 22, 2022 21:44 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | GrantCommon Stock | 16,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-007365 · doc1.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,989 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal quarterly installments on the 20th day of the second month of each calendar quarter beginning on May 20, 2022. Read SEC document |
| January 14, 2022 Filed Mar 1, 2022 18:43 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.952 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007229 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,174.494 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to reporting person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 17:40 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 2,400 | $127.76 | $306,624.00 |
DisclosureSEC source: 0001596783-21-000192 · wf-form4_163777561313540.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 0 F3 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $127.33 to $128.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 17:40 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 2,668 | $126.98 | $338,782.64 |
DisclosureSEC source: 0001596783-21-000192 · wf-form4_163777561313540.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 2,400 F1 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $126.27 to $127.26, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 21:15 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 4,271 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-045771 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,123 F1 · shares: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 17:35 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | PurchaseCommon Stock | 20,704 | $24.15 | $500,007.81 |
DisclosureSEC source: 0001567619-21-019589 · doc1.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,323 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $24.02 to $24.19. The reporting person undertakes to provide Berkeley Lights, Inc (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 28, 2021 Filed Nov 1, 2021 12:01 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 1,402 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-21-000174 · wf-form4_163576805469567.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,109 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2022 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 08, 2021 Filed Oct 12, 2021 20:56 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.523 | $60.01 | $331.44 |
DisclosureSEC source: 0001127602-21-026972 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,168.542 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:02 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.156 | $64.18 | $330.91 |
DisclosureSEC source: 0001127602-21-021893 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,163.019 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 17:06 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | PurchaseCommon Stock | 5,000 | $41.12 | $205,590.00 |
DisclosureSEC source: 0001567619-21-011783 · doc1.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Lucier Family Trust Disclosed balance after: 253,619 F1 · price: The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $41.025 to $41.12. The reporting person undertakes to provide Berkeley Lights, Inc (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · ownership.nature: As trustee of the Lucier Family Trust (the "Trust"), Mr. Lucier may be deemed to beneficially own the shares held by the Trust. Mr. Lucier disclaims beneficial ownership of the shares held by the Trust except to the extent of his pecuniary interest therein. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 20:42 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3,008 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018522 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,157.863 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 18, 2021 Filed May 20, 2021 18:01 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 3,095 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034566 · doc4.xml · derivative · entry 7 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,095 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F8 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 28, 2020 and is fully vested. F8 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 28, 2020 and is fully vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 18:01 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 2,577 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034566 · doc4.xml · derivative · entry 6 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,577 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F7 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 9, 2019 and is fully vested. F7 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 9, 2019 and is fully vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 18:01 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 3,725 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034566 · doc4.xml · derivative · entry 5 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F6 · derivative.exercise_date: This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested. F6 · derivative.expiration_date: This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 18:01 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 1,416 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034566 · doc4.xml · derivative · entry 4 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,416 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5 · derivative.exercise_date: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. F5 · derivative.expiration_date: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 18:01 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionRSUs · Derivative | 8,312 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034566 · doc4.xml · derivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5 · derivative.exercise_date: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. F5 · derivative.expiration_date: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. Read SEC document |
| May 18, 2021 Filed May 20, 2021 18:01 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 8,405 | $70.34 | $591,207.70 |
DisclosureSEC source: 0001209191-21-034566 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 257,939 F3 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F2 · balance_after: Shares indirectly held by the Reporting Person. Read SEC document |
| May 18, 2021 Filed May 20, 2021 18:01 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 19,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-034566 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 266,344 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On May 18, 2021, the Reporting Person retired from his position as a member of the Issuer's Board of Directors. Pursuant to deferral elections made by the Reporting Person, all shares underlying Restricted Stock Units ("RSUs") subject to such deferrals will be delivered to the Reporting Person promptly following May 18, 2021, the date on which the Reporting Person retired. F2 · balance_after: Shares indirectly held by the Reporting Person. Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:41 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | GrantStock Option (Right to Buy) · Derivative | 4,900 | $0.00 Strike: $37.13 | $0.00 |
DisclosureSEC source: 0001567619-21-010674 · doc1.xml · derivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900 Underlying: Common Stock · 4,900 shares Expires 2031-05-13 F3 · derivative.exercise_date: The stock option will fully vest on May 14, 2022. Read SEC document |
| May 14, 2021 Filed May 18, 2021 21:41 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | GrantCommon Stock | 1,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-010674 · doc1.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 248,619 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest on May 14, 2022 and have no expiration date. F2 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:50 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 4,046 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029999 · doc4.xml · derivative · entry 4 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,046 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 4,046 shares on April 30, 2021. F5 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 4,046 shares on April 30, 2021. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:50 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 38,527 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029999 · doc4.xml · derivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 38,527 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 38,527 shares on April 30, 2021. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on April 30, 2018. In accordance with the terms of the PRSU award, the award vested as to 38,527 shares on April 30, 2021. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:50 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 16,722 | $71.45 | $1,194,786.90 |
DisclosureSEC source: 0001209191-21-029999 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 247,219 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| April 30, 2021 Filed May 4, 2021 17:50 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 42,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-029999 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 263,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
| April 09, 2021 Filed Apr 12, 2021 21:27 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 7.828 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-013653 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,149.863 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 04, 2021 Filed Mar 4, 2021 21:11 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 5,000 | $58.95 | $294,750.00 |
DisclosureSEC source: 0001127602-21-009395 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,142.035 F1 · shares: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $58.93 to $58.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 04, 2021 Filed Mar 5, 2021 21:33 UTC Amendment | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 9,000 | $58.75 | $528,751.80 |
DisclosureSEC source: 0001127602-21-009530 · form4a.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Gregory Lucier IRA Disclosed balance after: 9,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $58.50 to $58.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 10, 2021 Filed Feb 12, 2021 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantPRSUs · Derivative | 4,045 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-010324 · doc4.xml · derivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,045 Underlying: Common Stock · 4,045 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2020. On February 10, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 4,045 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's non-GAAP Operating Margin over the performance period ended December 31, 2020. On February 10, 2021, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 4,045 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 21:33 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 9.24 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-001507 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,142.035 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. F2 · balance_after: Balance includes an additional 34 accrued dividends. Read SEC document |
| November 24, 2020 Filed Nov 26, 2020 00:52 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | PurchaseClass A Common Stock | 15,000 | $27.00 | $405,000.00 |
DisclosureSEC source: 0000899243-20-032217 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,852 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.